Gujarat Themis Biosyn Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

1 hour ago
share
Share Via
Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting an upgrade in its Mojo Grade from Sell to Hold as of 18 Aug 2026. Despite a modest day gain of 1.20%, the stock’s technical indicators present a nuanced picture, reflecting both bullish and bearish signals across different timeframes.
Gujarat Themis Biosyn Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

The stock closed at ₹428.45 on 16 Sep 2026, up from the previous close of ₹423.35, with intraday highs reaching ₹438.65 and lows of ₹417.45. This places the current price comfortably above its 52-week low of ₹225.75, though still shy of the 52-week high of ₹479.45. The technical trend has shifted from bullish to mildly bullish, signalling a cautious optimism among traders and investors.

Daily moving averages remain bullish, indicating that short-term momentum is positive. However, the weekly and monthly technical indicators reveal a more complex scenario, with some oscillators signalling caution.

MACD and RSI: Divergent Signals

The Moving Average Convergence Divergence (MACD) indicator remains bullish on both weekly and monthly charts, suggesting sustained upward momentum in the medium to long term. This is a positive sign for investors looking for trend confirmation beyond daily fluctuations.

Conversely, the Relative Strength Index (RSI) presents a bearish signal on the weekly timeframe, indicating potential short-term weakness or overbought conditions. The monthly RSI, however, shows no clear signal, reflecting a neutral stance over a longer horizon. This divergence between MACD and RSI highlights the importance of a multi-timeframe analysis when assessing the stock’s momentum.

Bollinger Bands and KST: Mixed Momentum Indicators

Bollinger Bands are bullish on both weekly and monthly charts, implying that price volatility is currently supporting an upward trend. This aligns with the MACD’s positive outlook and suggests that the stock price is trading near the upper band, often a sign of strength.

In contrast, the Know Sure Thing (KST) oscillator is mildly bearish on both weekly and monthly timeframes, signalling a potential slowdown in momentum or a consolidation phase. This mild bearishness in KST tempers the otherwise optimistic signals from Bollinger Bands and MACD.

Additional Technical Indicators and Dow Theory Assessment

On the volume front, the On-Balance Volume (OBV) indicator shows no discernible trend on either weekly or monthly charts, suggesting that volume is not currently confirming price movements. This lack of volume confirmation may warrant caution for momentum traders.

Dow Theory analysis reveals no clear trend on the weekly chart but indicates a mildly bullish trend on the monthly timeframe. This suggests that while short-term price action may be indecisive, the longer-term outlook remains cautiously positive.

Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!

  • - Hidden turnaround gem
  • - Solid fundamentals confirmed
  • - Large Cap opportunity

Discover This Hidden Gem →

Comparative Returns and Market Context

Gujarat Themis Biosyn Ltd’s performance relative to the Sensex over various periods underscores its resilience and growth potential. Over the past week, the stock declined by 5.44%, underperforming the Sensex’s 2.08% drop. However, over the last month, the stock surged 22.75%, significantly outperforming the Sensex’s 5.13% decline.

Year-to-date returns show a modest loss of 3.16% for the stock, yet this is notably better than the Sensex’s 13.16% decline. Over the last year, the stock gained 12.69%, contrasting with the Sensex’s 9.52% loss. The longer-term returns are particularly impressive, with a three-year gain of 258.99% versus the Sensex’s 9.09%, a five-year gain of 544.48% compared to 26.02%, and a remarkable ten-year return of 6391.67% against the Sensex’s 160.46%.

These figures highlight Gujarat Themis Biosyn Ltd’s strong growth trajectory and its ability to outperform the broader market significantly over extended periods, despite short-term volatility.

Mojo Score and Grade Upgrade

The company’s Mojo Score currently stands at 50.0, reflecting a balanced outlook. The recent upgrade from a Sell to a Hold grade on 18 Aug 2026 signals improved investor sentiment and technical conditions. This upgrade is supported by the bullish MACD and Bollinger Bands, alongside the daily moving averages’ positive stance.

However, the mixed signals from RSI and KST, coupled with the absence of volume confirmation, suggest that investors should maintain a cautious approach and monitor developments closely.

Gujarat Themis Biosyn Ltd or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Investor Takeaway and Outlook

Gujarat Themis Biosyn Ltd’s recent technical parameter changes reflect a stock in transition. The bullish MACD and Bollinger Bands, combined with daily moving averages, suggest that upward momentum is intact, particularly over the medium to long term. However, the bearish weekly RSI and mildly bearish KST indicators imply that short-term price action may experience some consolidation or correction.

Investors should weigh these mixed signals carefully. The lack of volume confirmation via OBV and the absence of a clear Dow Theory trend on the weekly chart further reinforce the need for prudence. The stock’s strong long-term returns relative to the Sensex provide a compelling backdrop, but near-term volatility remains a factor.

Given the current Mojo Grade of Hold, investors might consider maintaining positions while monitoring technical developments closely. Those seeking more aggressive exposure may wait for clearer confirmation from short-term indicators before increasing allocations.

Overall, Gujarat Themis Biosyn Ltd presents a balanced risk-reward profile, with technical momentum shifting cautiously towards the bullish side but tempered by some bearish signals. This nuanced outlook underscores the importance of a comprehensive, multi-indicator approach to technical analysis in the Pharmaceuticals & Biotechnology sector.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News